Literature DB >> 20492

Everted rat intestinal sacs as an in vitro model for assessing absorptivity of new drugs.

Z T Chowhan, A A Amaro.   

Abstract

An in vitro model that utilizes everted rat intestinal sacs was evaluated for assessing the absorptivity of several analogs of potential drug substances prior to formulation work and clinical trials. This model not only is a useful qualitative tool for assessing absorptivity of structurally related compounds but also yields some insight into the process involved in drug absorption. Notwithstanding the complexities involved in the absorption processes, the data support the hypothesis that the absorption of organic electrolytes mainly takes place by the partitioning of the unionized species into the lipoidal membranes and then diffusion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 20492     DOI: 10.1002/jps.2600660911

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  3 in total

1.  Development of an in vitro rat intestine segmental perfusion model to investigate permeability and predict oral fraction absorbed.

Authors:  Marc-Etienne Castella; Marianne Reist; Joachim M Mayer; Jean-Jacques Turban; Bernard Testa; Claire Boursier-Neyret; Bernard Walther; Jean-Marie Delbos; Pierre-Alain Carrupt
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

2.  The effect of activated dimethicone, other antacid constituents, and kaolin on the absorption of propranolol.

Authors:  J C McElnay; P F D'Arcy; J K Leonard
Journal:  Experientia       Date:  1982-05-15

3.  Robotically handled whole-tissue culture system for the screening of oral drug formulations.

Authors:  Thomas von Erlach; Sarah Saxton; Yunhua Shi; Daniel Minahan; Daniel Reker; Farhad Javid; Young-Ah Lucy Lee; Carl Schoellhammer; Tina Esfandiary; Cody Cleveland; Lucas Booth; Jiaqi Lin; Hannah Levy; Sophie Blackburn; Alison Hayward; Robert Langer; Giovanni Traverso
Journal:  Nat Biomed Eng       Date:  2020-04-27       Impact factor: 25.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.